Literature DB >> 16816977

Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.

Ramesh C Juyal1, Mitashree Das, Sohan Punia, Madhuri Behari, Geetika Nainwal, Sumit Singh, Pazhayannur V Swaminath, Shyla T Govindappa, Sachi Jayaram, Uday B Muthane, B K Thelma.   

Abstract

The depletion of dopamine levels in the brain due to degeneration of dopaminergic neurons of substantia nigra pars compacta is a hallmark of Parkinson's disease (PD). The cumulative contribution of genetic variations in genes from the dopaminergic pathway has been widely implicated to confer susceptibility to idiopathic PD. We present in this paper an extensive association analysis of a total of 20 markers including single nucleotide polymorphism/short tandem repeat/variable number tandem repeat/duplication markers from five candidate genes (namely, dopamine receptors DRD1, DRD2, DRD3, and DRD4, and dopamine transporter) with PD among two independent sample sets. The allelic, genotypic, and haplotypic association of these markers with PD was tested in South Indian (SI) samples (147 cases, 130 controls) and replicated in a larger North Indian (NI) sample set (340 cases, 344 controls). Of the several markers analyzed, 120 bp duplication marker of DRD4 gene showed promising results with PD in both of the sample sets. A significant allelic association in SI [odds ratio, OR (95% confidence interval, CI)=0.67 (0.47-0.97) for 120 bp dup; 1.48 (1.03-2.13) for 120 bp WT] and genotypic association in SI [OR (95% CI)= 0.56 (0.35-0.91) for 120 bp dup/dup; 1.62 (0.99-2.64) for 120 bp dup/120 bp WT] and in NI [OR (95% CI)= 1.41 (1.03-1.93) for 120 bp dup/120 bp WT] was observed. This is the first report on the association of dopaminergic gene polymorphisms with PD from the Indian sub-continent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816977     DOI: 10.1007/s10048-006-0048-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  42 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.

Authors:  Eng-King Tan; Yanni Tan; Anthea Chai; Christopher Tan; Hui Shen; Sau-Ying Lum; Stephanie M C Fook-Cheong; Mei-Ling Teoh; Yuan Yih; Meng-Cheong Wong; Yi Zhao
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

Review 3.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Pre-Caucasoid and Caucasoid genetic features of the Indian population, revealed by mtDNA polymorphisms.

Authors:  G Passarino; O Semino; L F Bernini; A S Santachiara-Benerecetti
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

Review 5.  MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.

Authors:  S H Snyder; R J D'Amato
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

6.  Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a Chinese population.

Authors:  D C Wan; L K Law; D T Ip; W T Cheung; W K Ho; K W Tsim; R Kay; J Woo; C P Pang
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

7.  Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4).

Authors:  M I Seaman; J B Fisher; F Chang; K K Kidd
Journal:  Am J Med Genet       Date:  1999-12-15

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.

Authors:  Y Okuyama; H Ishiguro; M Toru; T Arinami
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

10.  Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.

Authors:  V S Basile; M Masellis; F Badri; A D Paterson; H Y Meltzer; J A Lieberman; S G Potkin; F Macciardi; J L Kennedy
Journal:  Neuropsychopharmacology       Date:  1999-07       Impact factor: 7.853

View more
  9 in total

1.  Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting.

Authors:  Nidhi Jatana; Lipi Thukral; N Latha
Journal:  J Mol Model       Date:  2015-12-17       Impact factor: 1.810

2.  A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.

Authors:  Parvoneh Poorkaj; Wendy H Raskind; James B Leverenz; Mark Matsushita; Cyrus P Zabetian; Ali Samii; Sophia Kim; Nayiry Gazi; John G Nutt; John Wolff; Dora Yearout; J Lynne Greenup; Ellen J Steinbart; Thomas D Bird
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

3.  Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.

Authors:  V McGuire; S K Van Den Eeden; C M Tanner; F Kamel; D M Umbach; K Marder; R Mayeux; B Ritz; G W Ross; H Petrovitch; B Topol; R A Popat; S Costello; A D Manthripragada; A Southwick; R M Myers; L M Nelson
Journal:  J Neurol Sci       Date:  2011-06-12       Impact factor: 3.181

4.  Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

Authors:  Yunlong Ma; Wenji Yuan; Xianzhong Jiang; Wen-Yan Cui; Ming D Li
Journal:  Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.590

Review 5.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

7.  No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs.

Authors:  Julia M Geissler; Marcel Romanos; Manfred Gerlach; Daniela Berg; Claudia Schulte
Journal:  Atten Defic Hyperact Disord       Date:  2017-02-07

8.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 9.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.